VEGFA and neoplasm: The receptors on mesenchymal stem cells (MSCs) can combine with vascular endothelial growth factor (VEGF) and PLT-derived growth factor, attach to vascular endothelial cells, and pass through the endodermis of tumor blood vessels, thus achieving the effect of responding to inflammatory factors and targeting tumor tissues [34].